Sutent Adjunctive Treatment of Differentiated Thyroid Cancer
NCT00668811
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
23
Enrollment
OTHER
Sponsor class
Conditions
Papillary Thyroid Cancer
Follicular Thyroid Cancer
Differentiated Thyroid Cancer
Interventions
DRUG:
SU011248, Sutent
Sponsor
Medstar Health Research Institute
Collaborators
[object Object]